XIST: A Potential Drug Target and Biomarker (G7503)

Target Name: XIST

NCBI ID: G7503

XIST

Other Name(s): SXI1 | SWD66 | LINC00001 | DXS1089 | X inactive specific transcript | NCRNA00001 | DXS399E | swd66 | XCE | XIC

XIST: A Potential Drug Target and Biomarker

XIST (X-linked Inhibitor of STAR-NOR 1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidney. It is a key regulator of the cell cycle, and plays a role in preventing the uncontrolled growth and division that can occur in cancer.

XIST is also a drug target, and has been identified as a potential target for a variety of drugs, including inhibitors of the DNA replication process, which can be useful in treating certain types of cancer. In addition, XIST has also been shown to be involved in a variety of cellular processes that are important for normal brain function, including the regulation of cell death and the development of neurodegenerative diseases.

The discovery and characterization of XIST was made by a team of researchers at the University of California, San Diego, led by Dr. Zhiping Zhao. Dr. Zhao and his team identified XIST as a protein that was expressed in a variety of tissues and was involved in the regulation of the cell cycle. They also showed that XIST was involved in the regulation of cell death, and that it played a role in the development of neurodegenerative diseases.

In addition to its potential as a drug target, XIST has also been shown to have a variety of potential applications in cancer research. For example, studies have shown that XIST can be used as a biomarker for the detection and treatment of certain types of cancer, such as breast cancer. In addition, XIST has also been shown to be involved in the regulation of the development and progression of many types of cancer, including neuro malignant tumors.

The identification and characterization of XIST as a potential drug target and biomarker has the potential to have a significant impact on the development of new treatments for a variety of diseases. As more research is conducted on XIST, it is likely that new treatments for cancer and other diseases will be developed that target this protein.

In conclusion, XIST is a protein that has the potential to be a drug target and biomarker. Its role in the regulation of the cell cycle and its involvement in the development of neurodegenerative diseases make it an attractive target for new treatments. Further research is needed to fully understand the potential applications of XIST in cancer research and to develop new treatments.

Protein Name: X Inactive Specific Transcript

The "XIST Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XIST comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets